Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
EverlyWell is a digital health company that offers consumer testing, virtual care, at-home collection tests, and digital results.
Kira Pharmaceuticals is a Biotechnology Research Company.
SAGE Therapeutics develops and delivers novel medicines for most debilitating and disabling central nervous system disorders.
Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair, and restore hearing.
Turning Point Therapeutics is a pharmaceutical company that discovers and develops precision medicines for cancer and other diseases.
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Pact Pharma is a developer of personalized adoptive T cell therapies designed for the eradication of solid tumors.
10X Genomics ELV solutions and security systems company that provides an innovative genomics platform.
Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.
Foresite Capital has invested in 129 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Foresite Capital's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical Device. The firm invests across 12 different industry categories.
Among tracked funding rounds, SAGE Therapeutics received $650.0M in a Post Ipo Equity round. Foresite Capital's total known invested capital is $9.5B.
Foresite Capital's average investment size is $110.7M across its portfolio of 129 companies.
Recent Foresite Capital portfolio additions include EverlyWell, Kira Pharmaceuticals, SAGE Therapeutics, Decibel Therapeutics, Turning Point Therapeutics. These companies were founded in 2020 or later.